CN114479037A - Biodegradable polyester elastomer material and preparation method thereof - Google Patents

Biodegradable polyester elastomer material and preparation method thereof Download PDF

Info

Publication number
CN114479037A
CN114479037A CN202111589684.XA CN202111589684A CN114479037A CN 114479037 A CN114479037 A CN 114479037A CN 202111589684 A CN202111589684 A CN 202111589684A CN 114479037 A CN114479037 A CN 114479037A
Authority
CN
China
Prior art keywords
reaction
polyester elastomer
sebacic acid
preparation
elastomer material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202111589684.XA
Other languages
Chinese (zh)
Other versions
CN114479037B (en
Inventor
贾亚听
何创龙
隋晓锋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Donghua University
Original Assignee
Donghua University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Donghua University filed Critical Donghua University
Priority to CN202111589684.XA priority Critical patent/CN114479037B/en
Publication of CN114479037A publication Critical patent/CN114479037A/en
Application granted granted Critical
Publication of CN114479037B publication Critical patent/CN114479037B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/68Polyesters containing atoms other than carbon, hydrogen and oxygen
    • C08G63/688Polyesters containing atoms other than carbon, hydrogen and oxygen containing sulfur
    • C08G63/6884Polyesters containing atoms other than carbon, hydrogen and oxygen containing sulfur derived from polycarboxylic acids and polyhydroxy compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14Macromolecular materials
    • A61L27/18Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54Biologically active materials, e.g. therapeutic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/58Materials at least partially resorbable by the body
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/68Polyesters containing atoms other than carbon, hydrogen and oxygen
    • C08G63/688Polyesters containing atoms other than carbon, hydrogen and oxygen containing sulfur
    • C08G63/6882Polyesters containing atoms other than carbon, hydrogen and oxygen containing sulfur derived from hydroxy carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/78Preparation processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412Tissue-regenerating or healing or proliferative agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00Materials characterised by their function or physical properties
    • A61L2400/12Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/32Materials or treatment for tissue regeneration for nerve reconstruction

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Materials For Medical Uses (AREA)

Abstract

The invention relates to a biodegradable polyester elastomer material and a preparation method thereof, which is obtained by carrying out melt condensation polymerization on monomers containing sebacic acid, glycerol, citric acid and L-cysteine. The polyester elastic material provided by the invention has good elasticity, biocompatibility and biodegradability, and molecular chains of the polyester elastic material are rich in active reactive functional groups of carboxyl and sulfydryl simultaneously, so that the polyester elastic material is convenient for functional modification, and has application prospects in different biomedical application fields.

Description

Biodegradable polyester elastomer material and preparation method thereof
Technical Field
The invention belongs to the technical field of polyester materials, and particularly relates to a biodegradable polyester elastomer material and a preparation method thereof.
Background
Biodegradable polyester materials are the most important class of materials in biodegradable synthetic polymer materials, and due to good biodegradability, the biodegradable polyester materials are receiving more and more attention and are widely used in various biomedical applications. Existing biodegradable polyester materials mainly include two broad classes, thermoplastic and thermosetting. Generally, thermoplastic polyesters have better mechanical strength, but have poor elasticity and slow degradation, such as polylactic acid (PLA), Polycaprolactone (PCL), and copolymers thereof, while thermosetting polyesters have better elasticity and degradability, such as polytrimethylene sebacate (PGS). Most of human tissues are soft tissues and are in certain dynamic environments, such as cardiac muscle, blood vessels, skin, organs and the like, and when the implant is used in the parts, the implant is constructed by selecting a material with better elasticity, so that the implant is more favorable for being matched with the human tissues. In addition, if the implant has a certain bioactivity, it will be more beneficial to have a beneficial interaction with the microenvironment in the body, to have a better functioning or to promote tissue repair. However, the existing biodegradable polyester elastic materials are mainly used as structural materials to provide mechanical support for various tissue engineering scaffolds or medical application devices, and maintain the structural integrity or mechanical matching requirements of the materials, and the materials are mostly chemically inert, and the molecular chains of the materials lack reactive functional groups. For example, molecular chains of PLA, PGA, and PCL are composed of ester bonds and fatty chains, and have no additional functional groups, while molecular chains of PGS have many-OH groups attached thereto, but have low-OH activity and are difficult to further react at room temperature. In short, the existing biodegradable polyester materials are difficult to directly modify the bioactivity due to the lack of reactive functional groups on the molecular chains. For functional modification of these materials, stents or devices, surface modification or blending modification of the materials is required, such as plasma or chemical agent treatment to generate some reactive functional groups on the surface of the materials, or blending with biological macromolecules with biological activity. This undoubtedly increases the complexity of the application, and in most cases these methods have some limitations, which cannot be flexibly adopted, and thus, it increases the difficulty for the practical application. Therefore, the development of biodegradable polyester elastic materials having reactive functional groups contributes to the flexible functionalization of tissue engineering scaffolds or medical devices, and is of great significance in promoting various developments and advances in the biomedical field.
Disclosure of Invention
The invention aims to solve the technical problem of providing a biodegradable polyester elastomer material and a preparation method thereof.
The invention relates to a polyester elastomer material shown in the following structure,
Figure BDA0003428695390000021
wherein n is not less than 1, R is H or-COCH2-or-CH2-。
The polyester elastomer is obtained by carrying out melt condensation reaction on raw materials containing sebacic acid, glycerol, citric acid and L-cysteine.
The invention provides a preparation method of a polyester elastomer material, which comprises the following steps:
melting monomers: mixing sebacic acid, glycerol, citric acid and L-cysteine, stirring under protective gas until the monomers are molten, and making a reaction system into a clear and transparent liquid;
esterification reaction: stirring a reaction system under the condition of normal pressure to perform esterification reaction;
pre-polymerization: reducing the reaction pressure, keeping a certain vacuum degree, continuously stirring the reaction system to react for a certain time for condensation polymerization to obtain a branched prepolymer with a certain molecular weight;
curing of the prepolymer: and (3) continuously reacting the purified or unpurified prepolymer for a certain time at a certain temperature and under a certain pressure to obtain the polyester elastomer material with certain elasticity.
The preferred mode of the above preparation method is as follows:
the molar ratio of the sebacic acid to the glycerol is 1: 0.4-1; the molar ratio of sebacic acid to citric acid is 1: 0.001-0.6; the molar ratio of the sebacic acid to the L-cysteine is 1: 0.001-0.5.
The melting temperature of the protective gas is 120-200 ℃; the protective gas is nitrogen, argon, helium and the like.
Further preferably, the melting temperature is 130-.
Adding or not adding a catalyst after the melting; the catalyst is one of stannous octoate, stannous chloride, stannous octoate/p-toluenesulfonic acid and stannous chloride/p-toluenesulfonic acid.
The temperature of the esterification reaction is 120-200 ℃, and the time is 0.01-20 h.
Further preferably, the esterification reaction temperature is 120-160 ℃, and the reaction time is 0.01-20 hours.
The reaction under vacuum condition is as follows: the reaction temperature is 100-220 ℃, the vacuum degree of the reaction system is 0.1-6000Pa, and the reaction time is 0.5-50 h; the prepolymer is purified.
Further preferably, the reaction temperature under the vacuum condition is 100-180 ℃, the vacuum degree of the reaction system is 0.1-6000Pa, and the reaction time is 0.5-50 hours.
The prepolymer purification steps are as follows: dissolving the prepolymer in a certain solvent, then dripping the polymer solution into deionized water for precipitation, and collecting the precipitate to obtain the purified prepolymer; the solvent in which the prepolymer is dissolved includes one or more of methanol, ethanol, acetone, tetrahydrofuran, N-dimethylformamide, dimethyl sulfoxide, dichloromethane, acetonitrile, and the like.
Preferably, the prepolymer is purified from 0 to 5 times.
The curing is as follows: the temperature is 50-180 ℃, the vacuum degree in the curing process is 0.1-6000Pa, and the curing time is 4-200 h.
The polyester elastomer material is applied to compounding PGSCC with other natural or artificial synthetic materials, so that the obtained compound has reactive functional groups of carboxyl and sulfydryl, and is convenient for functional modification. More specifically, for example, PGSCC and PLLA are used in a composite manner, a composite nanofiber membrane with carboxyl and sulfhydryl groups attached to the fiber surface is obtained through an electrospinning technology, some bioactive molecules such as cytokines, drugs and the like are grafted on the fiber surface by utilizing the reactivity of the carboxyl and the sulfhydryl groups, and the mechanical properties such as elasticity, modulus and the like of the composite fiber membrane are improved due to the introduction of the PGSCC, so that the obtained composite nanofiber membrane is more suitable for dura mater repair, wound healing, tissue regeneration and the like.
The invention specifically relates to a method for preparing a crosslinked polyester elastomer, which is characterized in that four monomers of sebacic acid, glycerol, citric acid and L-cysteine are melted, esterified under the action of a catalyst or no catalyst, then melted and condensed to form a branched high-molecular prepolymer, and the prepolymer is continuously solidified to form a crosslinked polyester elastomer with certain elasticity, namely poly (sebacic acid-citric acid-L-cysteine-glycerol) ester (abbreviated as PGSCC). The polyester elastic material has good biocompatibility, biodegradability and mechanical elasticity, and the molecular chain of the polyester elastic material is simultaneously rich in reactive functional groups of carboxyl and sulfydryl, so that functional modification is facilitated, and the polyester elastic material is a biodegradable polyester elastic material with both structural and functional properties.
Advantageous effects
(1) The reaction monomers adopted by the invention are metabolites or metabolic intermediates in vivo, and the biological safety is good.
(2) The obtained polyester elastic material has good elasticity, biocompatibility and biodegradability.
(3) The molecular chain of the obtained polyester elastic material is rich in reactive carboxyl and sulfydryl, namely, the polyester elastic material has two active functional groups at the same time, so that the polyester elastic material is convenient for functional modification and can be used as a functional elastic material.
Drawings
FIG. 1 is an infrared spectrum (FTIR) of the material obtained in example 1; 1732cm-1Where is the absorption peak of ester C ═ O, 1716cm-1The peak is the absorption peak of carboxyl group C ═ O, and the absorption peak of carboxyl group C ═ O is more abundant in the PGSCC spectrum than in the PGS spectrum, indicating that the molecular chain of PGSCC is rich in carboxyl group (-COOH).
FIG. 2 shows the NMR spectra of the material obtained in example 1: (1H-NMR); the peak at δ 1.06ppm on the PGSCC spectrum was ascribed to the mercapto hydrogen (-CH)2-SH) This indicates that the molecular chain of PGSCC is rich in thiol groups (-SH).
FIG. 3 is a graph of uniaxial tensile stress-strain for the material obtained in example 2; the test temperature was room temperature and the stretching rate was 20 mm/min.
FIG. 4 is a graph of cyclic tensile stress-strain for the material obtained in example 2; the test temperature is room temperature, the stretching rate is 10mm/min, the strain range is 5-50%, the cycle times are 10 times, and the residence time between cycles is 0 s.
FIG. 5 is a fluorescence micrograph of two nanofibers obtained from example 3.
FIG. 6 shows the results of experiments in which PGSCC obtained in example 2 supported cell proliferation. In particular to the experimental result of the gradual proliferation of mouse fibroblast (NIH3T3) on the surface of the material along with the increase of time, and the testing method is a CCK-8 method.
FIG. 7 shows the results of in vitro degradation experiments of PGSCC obtained in example 2; wherein (a) is the result of mass loss of the sample with increasing incubation time; b is the result of the change of the pH of the sample soaking solution along with the increase of the incubation time.
Detailed Description
The invention will be further illustrated with reference to the following specific examples. It should be understood that these examples are for illustrative purposes only and are not intended to limit the scope of the present invention. Further, it should be understood that various changes or modifications of the present invention may be made by those skilled in the art after reading the teaching of the present invention, and such equivalents may fall within the scope of the present invention as defined in the appended claims.
Example 1
(1) Adding 0.12mol of sebacic acid (national medicine, AR), 0.08mol of glycerol (national medicine, AR), 0.006mol of citric acid (national medicine, AR) and 0.012mol of L-cysteine (national medicine, AR) into a 250ml two-neck flask, stirring at 160 ℃ for 0.5h under the protection of nitrogen, completely melting the monomers, and forming a clear and transparent liquid by the system;
cooling to 140 ℃, and stirring for reaction for 4 hours;
(3) reducing the pressure to 3325Pa at 140 ℃, and stirring for reaction for 12h to obtain a prepolymer; (4) the prepolymer was dissolved by adding 100ml of ethanol, and then added dropwise to 400ml of deionized water, and the precipitate was collected and dried to obtain a purified prepolymer. (5) The prepolymer was cured at 100Pa, 80 ℃ for 60h to give a cured polyester elastomer (PGSCC).
Example 2
(1) Adding 0.12mol of sebacic acid (national drug, AR), 0.08mol of glycerol (national drug, AR), 0.03mol of citric acid (national drug, AR) and 0.015mol of L-cysteine (national drug, AR) into a 250ml two-neck flask, stirring for 0.5h at 160 ℃ under the protection of nitrogen, completely melting the monomers, and forming a clear and transparent liquid by the system;
(2) the temperature is reduced to 140 ℃, and the stirring reaction is carried out for 2 hours;
(3) reducing the pressure to 3325Pa at 140 ℃, and stirring for reaction for 8h to obtain a prepolymer;
(4) adding 100ml ethanol to dissolve the prepolymer, then adding 400ml deionized water dropwise, collecting precipitate, drying to obtain purified prepolymer, measuring its molecular weight by GPC, and obtaining Mn=3467(PDI=16.58);
(5) The prepolymer was cured at 100Pa, 80 ℃ for 24h to give a cured polyester elastomer (PGSCC).
The resulting material PGSCC was subjected to uniaxial tensile testing with the comparative material PGS. The samples were rectangular bars 20mm long/5 mm wide/1 mm thick, the test temperature was room temperature, the tensile rate was 20mm/min, and the clamp spacing was 10mm, as shown in fig. 3, and the results showed that the stress-strain curve of PGSCC was similar to that of typical vulcanized rubber, indicating that it was in a high elastic state at room temperature and had better elasticity, as shown by the tensile strength of PGSCC of 0.3-0.5MPa, modulus of elasticity <0.5MPa, and elongation at break > 180%.
The resulting material PGSCC was subjected to a cyclic tensile test with the comparative material PGS. The sample is a rectangular strip with the length of 20 mm/width of 5 mm/thickness of 1mm, the test temperature is room temperature, the stretching rate is 10mm/min, the strain range is 5-50%, the cycle time is 10 times, the residence time between cycles is 0s, and the distance between clamps is 10 mm. As shown in FIG. 4, the results indicate that PGSCC has good elasticity in the 5-50% strain range, and can be cyclically stretched without hysteresis loop on the cyclic stretching curve, and the stretching curve after 10 cycles of stretching almost completely coincides with the initial curve.
And (3) evaluating the cell compatibility of the obtained PGSCC material, wherein the test method is a CCK-8 method. Taking mouse fibroblast (NIH3T3) to1.0*104/cm2The number of the cells is planted on the surface of the material, the cells are incubated in a cell incubator at 37 ℃, the culture solution is discarded on days 1, 3 and 5 after the cells are inoculated, the cells are washed for 2 times by PBS, CCK-8 test solution is added, the cells are incubated for 2 hours at 37 ℃, 100 mu l of the test solution is taken to measure the absorbance of the cells at 450nm, the greater the absorbance, the greater the number of the cells, as shown in figure 6, the result shows that PGSCC can support the growth of the cells and has good cell compatibility.
And (3) evaluating the in-vitro degradability of the obtained PGSCC material, wherein the test method is a PBS solution soaking method. The PGSCC disc samples (diameter 8mm, thickness 1mm) were placed in PBS (pH 7.4, 5ml) solution, shaken at 37 ℃ and 100rpm for a certain period of time, the samples were removed, washed and dried, and the mass loss and the pH of the soak solution were measured, as shown in fig. 7, which revealed that PGSCC was degraded under in vitro conditions, and as the incubation time increased, the mass of PGSCC samples decreased continuously, and the pH of the soak solution decreased gradually.
Example 3
(1) Dissolving the PGSCC prepolymer obtained in example 2 and poly-L-lactic acid (PLLA, Jinandai handle, eta ═ 1.6gl/g) in hexafluoroisopropanol (Darri chemical, purity ≥ 97%) to prepare spinning solution, such as PLLA (1g) + PGSCC (1g) + hexafluoroisopropanol (10ml), under the process parameters (10kV voltage, 1ml/h advancing rate, receiving distance 15cm, obtaining PGSCC/PLLA composite nanofiber by electrostatic spinning technology, and then curing the nanofiber, wherein the curing conditions are 100Pa and 80 ℃ for 60h as described in example 2;
(2) obtaining pure PLLA nanofibers by the same method and spinning parameters;
(3) treating the same PLLA/PGSCC composite nanofiber sample by using Rhodamine B with amino and FITC with maleimide respectively, and modifying the sample by using two fluorescent dyes simultaneously; the PLLA nanofibers were also treated the same;
(4) two types of nanofiber samples of PLLA/PGSCC and PLLA were observed under a fluorescence microscope, and the two types of fibers were observed under excitation of blue light and green light, respectively, as shown in FIG. 5, it can be seen that the PLLA/PGSCC nanofibers, after being treated identically with two types of fluorescent dyes, were green under excitation of blue light and red under excitation of green light; the PLLA nanofibers do not develop color under blue light or green light excitation and cannot be observed.
Comparative example 1
(1) Adding 0.1mol of sebacic acid (Chinese medicine, AR) and 0.1mol of glycerol (Chinese medicine, AR) into a 250ml two-neck flask, stirring for 0.5h at 140 ℃ under the protection of nitrogen, completely melting the monomers, and forming a clear and transparent liquid in the system;
(2) the temperature is reduced to 120 ℃, and the stirring reaction is carried out for 24 hours;
(3) reducing the pressure to 3325Pa at 120 ℃, and stirring for reaction for 48 hours to obtain a prepolymer;
(4) the prepolymer was cured at 100Pa and 120 ℃ for 60 hours to give a cured polyester elastomer (PGS).

Claims (10)

1. A polyester elastomer material having the structure shown below,
Figure FDA0003428695380000011
wherein n is not less than 1, R is H or-COCH2-or-CH2-。
2. The polyester elastomer material according to claim 1, wherein the polyester elastomer is obtained by a melt condensation reaction of a raw material containing sebacic acid, glycerol, citric acid, and L-cysteine.
3. A method of preparing a polyester elastomeric material, comprising:
mixing sebacic acid, glycerol, citric acid and L-cysteine, melting under protective gas, carrying out esterification reaction under normal pressure, then carrying out reaction under vacuum condition to obtain prepolymer, and curing to obtain the polyester elastomer material.
4. The preparation method according to claim 3, wherein the molar ratio of the sebacic acid to the glycerol is 1: 0.4-1; the molar ratio of sebacic acid to citric acid is 1: 0.001-0.6; the molar ratio of the sebacic acid to the L-cysteine is 1: 0.001-0.5.
5. The method as claimed in claim 3, wherein the melting temperature under the protective gas is 120-200 ℃; the protective gas is one or more of nitrogen, argon and helium.
6. The method according to claim 3, wherein a catalyst is added after the melting; the catalyst is one of stannous octoate, stannous chloride, stannous octoate/p-toluenesulfonic acid and stannous chloride/p-toluenesulfonic acid.
7. The preparation method as claimed in claim 3, wherein the esterification reaction is carried out at a temperature of 120 ℃ and 200 ℃ for a period of 0.01 to 20 hours.
8. The preparation method according to claim 3, wherein the reaction under vacuum condition is: the reaction temperature is 100-220 ℃, the vacuum degree of the reaction system is 0.1-6000Pa, and the reaction time is 0.5-50 h; the prepolymer is purified.
9. The method according to claim 3, wherein the curing is: the temperature is 50-180 ℃, the vacuum degree in the curing process is 0.1-6000Pa, and the curing time is 4-200 h.
10. Use of the polyester elastomer material according to claim 1.
CN202111589684.XA 2021-12-23 2021-12-23 Biodegradable polyester elastomer material and preparation method thereof Active CN114479037B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111589684.XA CN114479037B (en) 2021-12-23 2021-12-23 Biodegradable polyester elastomer material and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111589684.XA CN114479037B (en) 2021-12-23 2021-12-23 Biodegradable polyester elastomer material and preparation method thereof

Publications (2)

Publication Number Publication Date
CN114479037A true CN114479037A (en) 2022-05-13
CN114479037B CN114479037B (en) 2022-11-25

Family

ID=81494830

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111589684.XA Active CN114479037B (en) 2021-12-23 2021-12-23 Biodegradable polyester elastomer material and preparation method thereof

Country Status (1)

Country Link
CN (1) CN114479037B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130231412A1 (en) * 2011-08-26 2013-09-05 Robert S. Langer Urethane-crosslinked biodegradable elastomers
CN104629026A (en) * 2015-02-15 2015-05-20 东华大学 Biomedical polybasic copolymerized crosslinked polyester elastomer material and preparation method thereof
CN109705359A (en) * 2018-12-27 2019-05-03 华东理工大学 A kind of poly- decanedioic acid of modified poly (ethylene glycol)-(PEGS) injectable bioelastomer and its preparation method and application

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130231412A1 (en) * 2011-08-26 2013-09-05 Robert S. Langer Urethane-crosslinked biodegradable elastomers
CN104629026A (en) * 2015-02-15 2015-05-20 东华大学 Biomedical polybasic copolymerized crosslinked polyester elastomer material and preparation method thereof
CN109705359A (en) * 2018-12-27 2019-05-03 华东理工大学 A kind of poly- decanedioic acid of modified poly (ethylene glycol)-(PEGS) injectable bioelastomer and its preparation method and application

Also Published As

Publication number Publication date
CN114479037B (en) 2022-11-25

Similar Documents

Publication Publication Date Title
Hou et al. Development and biocompatibility evaluation of biodegradable bacterial cellulose as a novel peripheral nerve scaffold
CN111205429B (en) Polyurethane material and preparation method thereof
Rostamian et al. Design and characterization of poly (glycerol-sebacate)-co-poly (caprolactone)(PGS-co-PCL) and its nanocomposites as novel biomaterials: The promising candidate for soft tissue engineering
Stankus et al. Fabrication of biodegradable elastomeric scaffolds with sub‐micron morphologies
Bölgen et al. In vitro and in vivo degradation of non-woven materials made of poly (ε-caprolactone) nanofibers prepared by electrospinning under different conditions
Panzavolta et al. Electrospun gelatin nanofibers: Optimization of genipin cross-linking to preserve fiber morphology after exposure to water
US5264540A (en) Aromatic polyanhydrides
CN1166505A (en) Absorbable copolymers and blends of 6,6,-dialkyl-1,4-dioxepan-2-one and its cyclic dimer
CN104744661A (en) Hydrophilic degradable segmented polyurethane as well as preparation method and application thereof
Sarvari et al. Conductive and biodegradable scaffolds based on a five-arm and functionalized star-like polyaniline–polycaprolactone copolymer with ad-glucose core
JPH0413337B2 (en)
EP1533366A1 (en) Chitosan/acidic biopolymer hybrid fiber and culture base for animal cells
CN104788695A (en) Preparation method of biodegradable polyurethane film material
Yang et al. Electrospun and photocrosslinked gelatin/dextran–maleic anhydride composite fibers for tissue engineering
KR100953366B1 (en) Nano fiber for tissue regeneration and fabrication method thereof
CN105504248B (en) The preparation and application of the linear degradable poly ester elastomer of controllable elasticity and SME
Sarvari et al. 3D scaffold designing based on conductive/degradable tetrapolymeric nanofibers of PHEMA-co-PNIPAAm-co-PCL/PANI for bone tissue engineering
CN114479037B (en) Biodegradable polyester elastomer material and preparation method thereof
Rahmani et al. Cross-linked PMS/PLA nanofibers with tunable mechanical properties and degradation rate for biomedical applications
Dodel et al. Modifying the mechanical properties of silk nanofiber scaffold by knitted orientation for regenerative medicine applications
CN116139344A (en) Bone repair material for promoting osteoblast formation and preparation method thereof
Shabannejad et al. Fabrication and characterization of electrospun scaffold based on polycaprolactone-aloe vera and polyvinyl alcohol for skin tissue engineering
CN111892703B (en) Biodegradable thermoplastic polyester elastic material and preparation method thereof
Massoumi et al. Polyanizidine and polycaprolactone nanofibers for designing the conductive scaffolds
Feng et al. Synthesis and characterization of degraded gelatin grafted poly (ɛ-caprolactone) copolymers

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant